Please assess the completion status of the following clinical trial:

Trial Title: Does VoltagE Guided Additional Ablation Improve Procedural Outcome of Atrial Fibrillation Ablation?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing first-time catheter ablation for AF.~* Willing and able to provide informed consent~* Age greater than or equal to 18 years.~Exclusion Criteria:~* Patients who have previously undergone AF ablation~* Patients with more than mild mitral valve stenosis or mechanical mitral valve replacement~* Patients with chronic renal impairment with creatinine clearance rate of \<30 mL/min~* Patients who are pregnant

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Additional posterior wall isolation (Type: EXPERIMENTAL): Operator will perform pulmonary vein isolation (PVI) and additional posterior wall isolation if low voltage area exists more than 10% of the left atrium
- Voltage-guided substrate homogenization (Type: EXPERIMENTAL): Operator will perform pulmonary vein antrum isolation (PVI) and additional substrate modification based on the degree of low voltage area.
- PVI only group (Type: ACTIVE_COMPARATOR): Operator will perform PVI only

Based on this trial design, predict the completion outcome and termination type (if applicable).